Whitehawk Therapeutics (WHWK) Enterprise Value (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Enterprise Value of -$123.0 million for Q1 2026, up 46.75% year-over-year from -$83.8 million in Q1 2025, and up 15.55% quarter-over-quarter from -$145.7 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Enterprise Value (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Enterprise Value data on file, last reported at -$123.0 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$123.0 million, up 46.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$123.0 million (up 46.75% YoY), and the FY2025 annual result was -$145.7 million, down 208.44% from the prior year.
- Enterprise Value improved to -$123.0 million in Q1 2026 per WHWK's latest filing, from -$145.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$47.2 million in Q4 2024 and troughed at -$287.3 million in Q3 2025.
- A 5-year average of -$138.8 million and a median of -$129.8 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 56.6% in 2024, then sank 358.75% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$172.6 million in 2022, then jumped by 36.92% to -$108.8 million in 2023, then jumped by 56.6% to -$47.2 million in 2024, then slumped by 208.44% to -$145.7 million in 2025, then climbed by 15.55% to -$123.0 million in 2026.
- Business Quant data shows WHWK's Enterprise Value at -$123.0 million in Q1 2026, -$145.7 million in Q4 2025, and -$287.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | -123.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123.04 Mn |
| Dec 31, 2025 | -145.70 Mn |
| Sep 30, 2025 | -287.27 Mn |
| Jun 30, 2025 | -177.20 Mn |
| Mar 31, 2025 | -231.06 Mn |
| Dec 31, 2024 | -47.24 Mn |
| Sep 30, 2024 | -62.62 Mn |
| Jun 30, 2024 | -78.57 Mn |
| Mar 31, 2024 | -88.27 Mn |
| Dec 31, 2023 | -108.85 Mn |
| Sep 30, 2023 | -119.34 Mn |
| Jun 30, 2023 | -134.89 Mn |
| Mar 31, 2023 | -151.17 Mn |
| Dec 31, 2022 | -172.56 Mn |
| Sep 30, 2022 | -183.01 Mn |
| Jun 30, 2022 | -118.74 Mn |
| Mar 31, 2022 | -129.80 Mn |
| Dec 31, 2021 | -148.99 Mn |
| Sep 30, 2021 | -161.38 Mn |
| Jun 30, 2021 | -36.82 Mn |